Stoke Therapeutics
Jennifer Burstein is the current Director at Stoke Therapeutics. Prior to this, they were the Senior Vice President of Finance at LOXO Oncology, Inc. from January 2015 to December 2019. From January 2006 to December 2015, they served as Vice President - Finance at Acorda Therapeutics. Jennifer was also Sr. Director - Accounting at Eyetech Inc. from January 2002 to December 2006, and Controller at Measurisk from January 2001 to December 2002. Additionally, Jennifer has experience as a Site Controller - MEETH at Lenox Hill Hospital from March 1998 to February 2001, and as a Consultant at Loeb & Troper from January 1997 to December 1998. Jennifer began their career as an Accountant at Berson and Corrado, CPAs from January 1995 to December 1997.
Jennifer Burstein has a MBA in Accounting from University at Buffalo.
This person is not in the org chart
This person is not in any teams
This person is not in any offices